Improving access to early cancer trials for underrepresented groups
Official title: Increasing Access and Participation to Early Phase Clinical Trials to the Underrepresented Populations
Funded at University of Kansas Medical Center · NIH-10862992 · Data updated 2026-11-12
This study is working to make it easier for minority and underserved communities to join early cancer treatment trials, so they can access new therapies that could save lives, while also making sure these treatments are tested on a diverse group of people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | August 7, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $159,574 |
| NIH project number | 1R50CA290098-01 |
| Project ID | NIH-10862992 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include minority and underserved individuals diagnosed with cancer who may benefit from early phase clinical trials.
✕Less likely to help
Patients who are not diagnosed with cancer or those who do not belong to underrepresented populations may not receive benefit from this research.
What this research studies
This research aims to enhance access and participation in early phase clinical trials for minority and underserved populations, particularly in cancer treatment. It focuses on developing sustainable strategies to engage these groups, ensuring they can access potentially life-saving therapies that are not yet commercially available. The project will utilize lessons learned from previous initiatives to create effective outreach and support mechanisms, addressing the complexities of early phase trials that often limit participation. By increasing representation in these trials, the research seeks to ensure that new cancer therapies are evaluated for their effectiveness across diverse populations.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options and outcomes for underrepresented populations.
How similar studies have gone: Previous initiatives have shown success in increasing participation of underrepresented groups in clinical trials, indicating that this approach has potential.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Baranda, Joaquina C — University of Kansas Medical Center
- Study coordinator: Baranda, Joaquina C
Related research
Other NIH-funded projects on the same topics.
-
Motor-Cognitive Training for Older Adults at Risk of Dementia
A Phase II trial tests a combined motor and cognitive training program for older adults at risk of dementia to see if it helps daily function and slows dementia onset.
-
MOVE Peds: Moving Toward Better Outcomes for Pediatric FSHD
A study in kids with a rare muscle disease (FSHD) will test how well certain outcomes reflect change and help guide future clinical trials.
-
How DNA methylation changes in our cells affect gene activity
This project studies how chemical changes to DNA, and the way DNA is packaged, influence how genes turn on or off in vertebrate cells.
-
Dietary oxysterols and metabolic dysfunction in the gut-liver axis
Aims to understand how oxidized cholesterol byproducts in processed foods affect gut and liver health, especially in adults with type 2 diabetes or related conditions.
-
Intermittent fasting and blood sugar in adults with diabetes
A study will look at how two forms of intermittent fasting might improve blood sugar control in adults with type 2 diabetes.
-
Dysfunctional fat tissue and its link to fatty liver and diabetes
Researchers are studying how problems in fat tissue contribute to fatty liver disease and type 2 diabetes in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.